| Literature DB >> 29720193 |
Hatoko Sasaki1, Naoko Kakee2, Naho Morisaki3, Rintaro Mori4, Ulrike Ravens-Sieberer5, Monika Bullinger6.
Abstract
BACKGROUND: This study examined the reliability and validity of the Japanese versions of the DISABKIDS-37 generic modules, a tool for assessing the health-related quality of life (HRQOL) of children and adolescents with a chronic condition.Entities:
Keywords: Adolescents; Assessment; Children; Chronic conditions; Health-related quality of life; Validation
Mesh:
Year: 2018 PMID: 29720193 PMCID: PMC5932858 DOI: 10.1186/s12955-018-0911-1
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Socio-demographic and clinical characteristics of the sample
| Children/adolescents ( | Parents/caregivers (N = 123) | |
|---|---|---|
| Age years, Mean (SD) | 12.3 (3.1) | 45.0 (5.5) |
| Age group, n (%) | ||
| Children (8–12 years) | 63 (51.2) | |
| Adolescents (13–18 years) | 60 (48.8) | |
| Gender | ||
| Male | 66 (53.7) | 16 (13.0) |
| Female | 57 (46.3) | 103 (83.7) |
| Unanswered | 4 (3.3) | |
| Marital status: married, n (%) | 111 (90.2) | |
| Economic status (living condition), n (%) | ||
| Very comfortable | 6(4.9) | |
| Somewhat comfortable | 43(35) | |
| Somewhat difficult | 60(48.8) | |
| Very difficult | 11(8.9) | |
| Unanswered | 3(2.4) | |
| Clinical characteristics, n (%) | ||
| Allergies | 70 (56.9) | |
| Endocrine Disease | 25 (20.3) | |
| Circulatory disease | 13 (10.6) | |
| Kidney disease | 11 (8.9) | |
| Collagen Disease | 4 (3.3) | |
Psychometric properties for the total score of the Japanese DISABKIDS Chronic generic module (self-report version / parent version)
| Domain | Facet | N | Mean | SD | %floor | %ceiling | Skewness | Cronbach α | Split-half | ICC | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DISABKIDS | Mental | Independence | 123/122 | 73.1/70.6 | 16.9/18.2 | 0.0/0.0 | 3.3/6.6 | − 0.7/− 0.5 | 0.74/0.86 | 0.74/0.81 | 0.71/− |
| Emotion | 123/123 | 74.8/66.3 | 19.4/20.4 | 0.0/0.8 | 8.1/4.9 | −0.7/−0.7 | 0.82/0.92 | 0.84/0.91 | 0.70/− | ||
| Social | Social inclusion | 123/122 | 73.3/72.2 | 20/18.5 | 0.0/0.0 | 9.8/8.2 | −1.0/−0.6 | 0.78/0.80 | 0.81/0.86 | 0.70/− | |
| Social exclusion | 122/123 | 81.2/74.9 | 18.1/19.4 | 0.0/0.0 | 20.3/11.4 | −1.3/−0.8 | 0.75/0.87 | 0.71/0.83 | 0.74/− | ||
| Physical | Physical | 121/123 | 73.1/67.4 | 21.8/20.8 | 0.0/0.0 | 10.7/5.7 | −0.8/− 0.5 | 0.79/0.86 | 0.75/0.85 | 0.73/− | |
| Treatment | 110/113 | 74.9/62.3 | 20.7/21.7 | 0.0/0.0 | 18.2/4.4 | −0.6/−0.4 | 0.77/0.88 | 0.68/0.87 | 0.64/− | ||
| Total score | 123/123 | 75.1/70.2 | 16/16.2 | – | – | −1.1/−0.6 | 0.92/0.95 | 0.84/0.85 | 0.77/− | ||
ICC: Infraclass correlation coefficients (ICC) between self-report version and proxy-report version of the Japanese DISABKIDS measure
Test-retest reliability correlation (self-report version / parent version)
| Domain | Facet | Children ( | Adolescents ( | |||
|---|---|---|---|---|---|---|
| Pearson r | ICC | Pearson r | ICC | |||
| DISABKIDS | Mental | Independence | 0.69/0.78 | 0.81/0.87 | 0.83/0.81 | 0.90/0.89 |
| Emotion | 0.65/0.83 | 0.78/0.90 | 0.82/0.86 | 0.90/0.92 | ||
| Social | Social inclusion | 0.79/0.88 | 0.88/0.93 | 0.83/0.92 | 0.91/0.96 | |
| Social exclusion | 0.75/0.89 | 0.85/0.94 | 0.74/0.82 | 0.85/0.90 | ||
| Physical | Physical limitation | 0.47/0.84 | 0.64/0.90 | 0.84/0.81 | 0.91/0.89 | |
| Treatment | 0.68/0.87 | 0.81/0.93 | 0.74/0.82 | 0.85/0.93 | ||
| Total score | 0.83/0.94 | 0.90/0.97 | 0.89/0.93 | 0.94/0.96 | ||
All correlations are significant, P < 0.01
Intercorrelation (Pearson r) between total score and sub-scales of the self-report version and parent version
| Self-report/ proxy-report | ||||||
|---|---|---|---|---|---|---|
| Independence | Emotion | Social inclusion | Social exclusion | Physical limitation | Treatment | |
| Children (n = 63) | ||||||
| Emotion | 0.61**/0.61** | |||||
| Social inclusion | 0.60**/0.57** | 0.57**/0.28* | ||||
| Social exclusion | 0.65**/0.59** | 0.70**/0.69** | 0.63**/0.42** | |||
| Limitation | 0.56**/0.61** | 0.71**/0.71** | 0.60**/0.39** | 0.73**/0.76** | ||
| Treatment | 0.08/0.05 | 0.34*/0.53** | −0.06/−0.06 | −0.01/0.45** | 0.16/0.39** | |
| Total score | 0.77**/0.75** | 0.89**/0.87** | 0.78**/0.55** | 0.84**/0.86** | 0.87**/0.86** | 0.34*/0.59** |
| Adolescents (n = 60) | ||||||
| Emotion | 0.71**/0.74** | |||||
| Social inclusion | 0.58**/0.54** | 0.485**/0.31* | ||||
| Social exclusion | 0.58**/0.61** | 0.64**/0.62** | 0.49**/0.63** | |||
| Limitation | 0.62**/0.71** | 0.66**/0.80** | 0.60**/0.54** | 0.68**/0.77** | ||
| Treatment | −0.04/0.47** | 0.10/0.65** | 0.09/0.16 | 0.19/0.33* | 0.17/0.40** | |
| Total score | 0.79**/0.85** | 0.81**/0.88** | 0.73**/0.66** | 0.79**/0.83** | 0.88**/0.90** | 0.32*/0.65** |
| Cross-cultural samplea | ||||||
| Emotion | 0.52/0.55 | |||||
| Social inclusion | 0.57/0.60 | 0.40/0.49 | ||||
| Social exclusion | 0.49/0.55 | 0.57/0.68 | 0.46/0.55 | |||
| Limitation | 0.41/0.42 | 0.62/0.64 | 0.42/0.34 | 0.36/0.42 | ||
| Treatment | 0.31/0.33 | 0.60/0.55 | 0.24/0.30 | 0.44/0.49 | 0.37/0.36 | |
| Total score | 0.72/0.73 | 0.86/0.88 | 0.67/0.70 | 0.73/0.81 | 0.72/0.71 | 0.71/0.70 |
aThe DISABKIDS Group Europe, n = 1152, age group 8–16. (Schmidt et al., [16])
*P < 0.05, **P < 0.01
Correlation coefficients (Pearson r) for total score and sub-scales of the self-report and parent versions with KIDSCREEN (self-report and parent versions)
| Independence | Emotion | Social inclusion | Social exclusion | Physical limitation | Treatment | Total score | ||
|---|---|---|---|---|---|---|---|---|
| KIDSCREEN | Children | |||||||
| Self-report version | 0.44** | 0.54# | 0.48# | 0.38** | 0.37** | 0.41** | 0.60# | |
| Parent version | 0.55# | 0.55# | 0.59# | 0.56# | 0.52# | 0.39** | 0.68# | |
| Adolescents | ||||||||
| Self-report version | 0.65# | 0.50# | 0.65# | 0.60# | 0.61# | 0.08 | 0.71# | |
| Parent version | 0.67# | 0.48# | 0.58# | 0.54# | 0.61# | 0.41** | 0.68# | |
| Cross-cultural samplea (self/proxy) | 0.70/0.79 | 0.84/0.92 | 0.68/0.74 | 0.77/0.83 | 0.70/0.79 | 0.80/0.85 | 0.91/0.94 | |
aThe DISABKIDS Group Europe, n = 1152, age group 8–16 (Schmidt et al., [16]) *p < 0.05, **p < 0.01, #p < 0.001
Comparisons of the dimension scores for self-report version according to gender, age group, economic status and clinical characteristics
| Independence | Emotion | Social inclusion | Social exclusion | Physical limitation | Treatment | Total score | |
|---|---|---|---|---|---|---|---|
| Gender | |||||||
| Boys | 74.2 ± 18.9 | 75.1 ± 21.3 | 73.5 ± 20.0 | 80.4 ± 18.7 | 74.1 ± 20.7 | 74.3 ± 24.9 | 74.5 ± 15.2 |
| Girls | 75.5 ± 17.9 | 78.1 ± 19.7 | 74.3 ± 17.9 | 82.1 ± 17.5 | 71.8 ± 23.1 | 71.9 ± 20.9 | 74.8 ± 15.6 |
| P values | 0.68 | 0.42 | 0.81 | 0.62 | 0.55 | 0.59 | 0.92 |
| Age group | |||||||
| Children | 77.8 ± 17.5 | 81.2 ± 19.3 | 74.8 ± 18.2 | 82.3 ± 19.8 | 78.2 ± 20.7 | 76.4 ± 22.3 | 77.8 ± 15.1 |
| Adolescents | 71.6 ± 19.0 | 71.5 ± 20.9 | 72.9 ± 19.8 | 79.9 ± 16.3 | 67.8 ± 21.8 | 70.0 ± 23.3 | 71.5 ± 15.0 |
| P values | 0.06 | 0.01 | 0.57 | 0.46 | 0.01 | 0.14 | 0.03 |
| Economic statusa | |||||||
| Comfortable | 79.6 ± 15.8 | 81.8 ± 16.3 | 77.5 ± 14.7 | 84.3 ± 16.5 | 75.0 ± 18.3 | 74.6 ± 21.8 | 78.4 ± 12.4 |
| Difficult | 71.3 ± 19.4 | 72.5 ± 22.5 | 71.1 ± 21.2 | 78.8 ± 18.9 | 71.6 ± 23.9 | 72.2 ± 23.7 | 72.3 ± 16.5 |
| | 0.01 | 0.01 | 0.05 | 0.09 | 0.38 | 0.60 | 0.04 |
| Clinical characteristicsb | |||||||
| Allergies | 77.0 ± 18.4 | 79.3 ± 20.0 | 75.6 ± 19.0 | 80.8 ± 19.1 | 76.2 ± 21.2 | 74.8 ± 21.3 | 77.4 ± 15.2 |
| Endocrine Disease | 68.2 ± 20.6 | 69.0 ± 21.9 | 70.3 ± 20.2 | 76.0 ± 18.8 | 65.0 ± 23.8 | 66.3 ± 27.0 | 68.8 ± 15.8 |
| Others | 75.2 ± 15.4 | 75.9 ± 19.9 | 72.7 ± 17.8 | 87.0 ± 13.0 | 72.6 ± 20.1 | 75.6 ± 23.4 | 71.7 ± 13.5 |
| P values | 0.12 | 0.10 | 0.46 | 0.09 | 0.09 | 0.28 | 0.06 |
Dimension scores are reported as mean standard deviation
a Economic status is recorded into two categories: Comfortable includes “Very comfortable” and “Somewhat comfortable”. Difficult includes “Somewhat difficult” and “Very difficult”
b P values: significance level of analysis of variance test. “Others” include Circulatory disease, Kidney disease, and Collagen Disease